carmustine
BCNU
 
Notes:
Isol. from the common clam Mercenaria mercenaria and from Mercenaria campechiensis Carmustine is one of the nitrosoureas indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in treatment of brain tumors, multiple myeloma, Hodgkin's disease, and non-Hodgkin's lymphomas. Although it is generally agreed that carmustine alkylates DNA and RNA, it is not cross resistant with other alkylators. As with other nitrosoureas, it may also inhibit several key enzymatic processes by carbamoylation of amino acids in proteins.
  • BOC Sciences
    • BOC Sciences
      Best of Chemicals Supplier
      Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
      BOC Sciences provides a wide range of services to support the pharmaceutical industry through all stages of drug discovery including Custom Synthesis of those chemicals that are not in stock, Isotope Labeling Service, Chiral Synthesis and Resolution, Bioconjugation, PEGylation services, analytical services.
      BOC Sciences is a brand of BOCSCI Inc. We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-informed decisions tailored to your evolving needs for premium chemicals. Our complete suite of CRO services spans the entire molecule development pipeline including contract research for target identification, building blocks, compound synthesis, biochemical and cellular analysis, preclinical animal tests, and clinical studies.
      Email: Marketing
      US Email: Marketing
      Email: Sales
      US Email: Sales
      Voice: 1-631-485-4226
      Fax: 1-631-614-7828
      US Voice: 1-631-485-4226
      US Fax: 1-631-614-7828
      Europe44-203-286-1088
      Facebook
      Twitter
      Linkedin
      Blog
      Get the App!
      Product(s):
      154-93-8 Carmustine >98%
      Carmustine is antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. This agent also carbamoylates proteins, including DNA
       
       
Synonyms   Articles   Notes   Search
CAS Number: 154-93-8Picture of molecule3D/inchi
Other(deleted CASRN): 1159711-15-5
ECHA EINECS - REACH Pre-Reg: 205-838-2
FDA UNII: U68WG3173Y
Nikkaji Web: J2.968H
Beilstein Number: 2049744
MDL: MFCD00057706
XlogP3: 1.50 (est)
Molecular Weight: 214.05013000
Formula: C5 H9 Cl2 N3 O2
NMR Predictor: Predict (works with chrome or firefox)
Category: natural substances and extractives
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar: Search
Google Books: Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents: Search
US Patents: Search
EU Patents: Search
Pubchem Patents: Search
PubMed: Search
NCBI: Search
Synonyms   Articles   Notes   Search   Top
Physical Properties:
Appearance: orange-yellow solid (est)
Assay: 95.00 to 100.00 % 
Food Chemicals Codex Listed: No
Soluble in:
 water, 4000 mg/L @ 25 °C (exp)
Synonyms   Articles   Notes   Search   Top
Organoleptic Properties:
 
Odor and/or flavor descriptions from others (if found).
 
 
Synonyms   Articles   Notes   Search   Top
Cosmetic Information:
None found
Synonyms   Articles   Notes   Search   Top
Suppliers:
BOC Sciences
For experimental / research use only.
Carmustine >98%
Odor: characteristic
Use: Carmustine is antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. This agent also carbamoylates proteins, including DNA
Sigma-Aldrich: Sigma
For experimental / research use only.
Carmustine ≥98%
Synonyms   Articles   Notes   Search   Top
Safety Information:
Preferred SDS: View
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
intravenous-child LDLo  78 mg/kg/52W-I
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES GASTROINTESTINAL: NAUSEA OR VOMITING BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE
Cancer Vol. 42, Pg. 74, 1978.

intravenous-dog LDLo  2 mg/kg
Cancer Chemotherapy Reports, Part 1. Vol. 57, Pg. 33, 1973.

oral-dog LDLo  5 mg/kg
Advances in Cancer Research. Vol. 16, Pg. 273, 1972.

parenteral-hamster LD10  18 mg/kg
Journal of Surgical Oncology. Vol. 15, Pg. 355, 1980.

intravenous-human TDLo  6 mg/kg
BLOOD: THROMBOCYTOPENIA GASTROINTESTINAL: NAUSEA OR VOMITING BLOOD: LEUKOPENIA
Cancer Treatment Reports. Vol. 60, Pg. 709, 1976.

intravenous-human TDLo  125 mg/kg
BLOOD: LEUKOPENIA BLOOD: THROMBOCYTOPENIA GASTROINTESTINAL: NAUSEA OR VOMITING
Advances in Cancer Research. Vol. 16, Pg. 273, 1972.

intramuscular-mouse LD50  86300 ug/kg
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" BEHAVIORAL: ATAXIA
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 9, Pg. 766, 1978.

intraperitoneal-mouse LD50  21260 ug/kg
National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986

intravenous-mouse LD50  45 mg/kg
Proceedings of the Society for Experimental Biology and Medicine. Vol. 118, Pg. 756, 1965.

oral-mouse LD50  19 mg/kg
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED"
Toxicology and Applied Pharmacology. Vol. 21, Pg. 405, 1972.

unreported-mouse LD50  42 mg/kg
Cancer Research. Vol. 46, Pg. 2703, 1986.

intramuscular-rat LD50  79600 ug/kg
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" BEHAVIORAL: ATAXIA
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 9, Pg. 766, 1978.

intraperitoneal-rat LD50  17420 ug/kg
National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986

intravenous-rat LD50  13800 ug/kg
LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE
Oncology. Vol. 37, Pg. 177, 1980.

oral-rat LD50  20 mg/kg
Journal of Pharmacology and Experimental Therapeutics. Vol. 166, Pg. 104, 1969.

Dermal Toxicity:
subcutaneous-mouse LD50 24 mg/kg
KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED"
Toxicology and Applied Pharmacology. Vol. 21, Pg. 405, 1972.

subcutaneous-rat LD50 83200 ug/kg
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" BEHAVIORAL: ATAXIA
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 9, Pg. 766, 1978.

Inhalation Toxicity:
Not determined
Synonyms   Articles   Notes   Search   Top
Safety in Use Information:
Category: natural substances and extractives
Recommendation for carmustine usage levels up to:
 not for fragrance use.
 
Recommendation for carmustine flavor usage levels up to:
 not for flavor use.
Synonyms   Articles   Notes   Search   Top
Safety References:
EPI System: View
ClinicalTrials.gov: search
Daily Med: search
Chemical Carcinogenesis Research Information System: Search
AIDS Citations: Search
Cancer Citations: Search
Toxicology Citations: Search
EPA GENetic TOXicology: Search
EPA ACToR: Toxicology Data
EPA Substance Registry Services (SRS): Registry
Laboratory Chemical Safety Summary : 2578
National Institute of Allergy and Infectious Diseases: Data
WGK Germany: 3
 1,3-bis(2-chloroethyl)-1-nitrosourea
Chemidplus: 0000154938
EPA/NOAA CAMEO: hazardous materials
RTECS: YS2625000 for cas# 154-93-8
Synonyms   Articles   Notes   Search   Top
References:
 1,3-bis(2-chloroethyl)-1-nitrosourea
NIST Chemistry WebBook: Search Inchi
Canada Domestic Sub. List: 154-93-8
Pubchem (cid): 2578
Pubchem (cas): 154-93-8
Synonyms   Articles   Notes   Search   Top
Other Information:
(IUPAC): Atomic Weights of the Elements 2011 (pdf)
Videos: The Periodic Table of Videos
tgsc: Atomic Weights use for this web site
(IUPAC): Periodic Table of the Elements
CHEBI: View
CHEMBL: View
KEGG (GenomeNet): C06873
HMDB (The Human Metabolome Database): HMDB14407
FooDB: FDB012974
VCF-Online: VCF Volatile Compounds in Food
ChemSpider: View
Wikipedia: View
Synonyms   Articles   Notes   Search   Top
Potential Blenders and core components note
 
None Found
 
Synonyms   Articles   Notes   Search   Top
Potential Uses:
None Found
Synonyms   Articles   Notes   Search   Top
Occurrence (nature, food, other): note
 clam
Search  PMC Picture
Synonyms   Articles   Notes   Search   Top
Synonyms:
 BCNU
 carmubris
bischloroethyl nitrosourea
1,3-bis(2-chloroethyl)-1-nitrosourea
N,N'-bis(2-chloroethyl)-N-nitrosourea
bis-N,N'-(chloroethyl)nitrosourea
Synonyms   Articles   Notes   Search   Top
Articles:
PubMed: Developing Therapies for Brain Tumors: The Impact of the Johns Hopkins Hunterian Neurosurgical Research Laboratory.
PubMed: Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
PubMed: Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
PubMed: Modeling mass transfer from carmustine-loaded polymeric implants for malignant gliomas.
PubMed: Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.
PubMed: Growth pattern of tumor recurrence following bis-chloroethylnitrosourea (BCNU) wafer implantation in malignant glioma.
PubMed: Establishing the standard of care for patients with newly diagnosed and recurrent glioblastoma.
PubMed: The chemopreventive effect of dimethylthiourea against carmustine-induced myelotoxicity in rats.
PubMed: Controversies in the adjuvant therapy of high-grade gliomas.
PubMed: Space-occupying cyst development in the resection cavity of malignant gliomas following GliadelĀ® implantation--incidence, therapeutic strategies, and outcome.
PubMed: Protective effect of N-acetylcysteine against carmustine-induced myelotoxicity in rats.
PubMed: Extended O6-methylguanine methyltransferase promoter hypermethylation following n-butylidenephthalide combined with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on inhibition of human hepatocellular carcinoma cell growth.
PubMed: Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells.
PubMed: Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.
PubMed: Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents.
PubMed: Recurrent malignant glioma in adults.
PubMed: Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
PubMed: Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
PubMed: In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
PubMed: Comparative study on the influence of two 2-chloroethylnitrosoureas with different carbamoylating potential towards glutathione and glutathione-related enzymes in different organs of the rat.
PubMed: Influence of glutathione on the mutagenicity of 2-chloroethylnitrosoureas. Mutagenic potential of glutathione derivatives formed from 2-chloroethylnitrosoureas and glutathione.
PubMed: A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
PubMed: Carcinogenic N-nitroso compounds and their environmental significance.
PubMed: Solid tumor chemotherapy: new drugs and horizons.
Synonyms   Articles   Notes   Search   Top
Please share your Comments.
Email Address:
 
 
 
 
Top of Page Home
Copyright © 1980-2021 Perflavory ™ Disclaimer Privacy Policy